110 related articles for article (PubMed ID: 18256093)
1. A total hip replacement infected with mycobacterium bovis after intravesicular treatment with Bacille-Calmette-Guérin for bladder cancer.
Reigstad O; Siewers P
J Bone Joint Surg Br; 2008 Feb; 90(2):225-7. PubMed ID: 18256093
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium bovis infection of total hip arthroplasty after intravesicular bacille Calmette-Guérin therapy.
Srivastava A; Ostrander J; Martin S; Walter N
Am J Orthop (Belle Mead NJ); 2011 Nov; 40(11):E226-8. PubMed ID: 22263218
[TBL] [Abstract][Full Text] [Related]
3. Prosthetic joint infection due to Mycobacterium bovis 5-years after BCG-instillations.
Goedertier W; Sioen W
Acta Orthop Belg; 2020 Jun; 86(2):239-242. PubMed ID: 33418613
[TBL] [Abstract][Full Text] [Related]
4. Impact of previous bacille Calmette-Guérin failure pattern on subsequent response to bacille Calmette-Guérin plus interferon intravesical therapy.
Gallagher BL; Joudi FN; Maymí JL; O'Donnell MA
Urology; 2008 Feb; 71(2):297-301. PubMed ID: 18308107
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium bovis osteomyelitis involving a hip arthroplasty after intravesicular bacille Calmette-Guérin for bladder cancer.
Guerra CE; Betts RF; O'Keefe RJ; Shilling JW
Clin Infect Dis; 1998 Sep; 27(3):639-40. PubMed ID: 9770167
[TBL] [Abstract][Full Text] [Related]
6. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes].
Iturralde Codina A; Beyríe Tamayo W; Gozá León F; Muñoz YI
Arch Esp Urol; 2004; 57(6):606-18. PubMed ID: 15382436
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium bovid infection of total knee arthroplasty after bacille Calmette-Guérin therapy for bladder cancer.
Rispler DT; Stirton JW; Gilde AK; Kane KR
Am J Orthop (Belle Mead NJ); 2015 Feb; 44(2):E46-8. PubMed ID: 25658082
[TBL] [Abstract][Full Text] [Related]
8. Clinical study of bladder cancer: Proteinuria as a predictor of recurrence and efficacy of intravesical bacille Calmette-Guerin therapy.
Satoh A; Hanawa Y; Nakamura S
Int J Urol; 2004 Jul; 11(7):476-82. PubMed ID: 15242355
[TBL] [Abstract][Full Text] [Related]
9. Infected total hip arthroplasty after intravesical bacillus Calmette-Guérin therapy.
Segal A; Krauss ES
J Arthroplasty; 2007 Aug; 22(5):759-62. PubMed ID: 17689788
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous BCG of the penis after intravesical therapy for bladder cancer: a case report in a 66-year-old male.
Hillyer S; Gulmi FA
Can J Urol; 2009 Oct; 16(5):4866-9. PubMed ID: 19796470
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.
Yossepowitch O; Eggener SE; Bochner BH; Donat SM; Herr HW; Dalbagni G
J Urol; 2006 Aug; 176(2):482-5. PubMed ID: 16813873
[TBL] [Abstract][Full Text] [Related]
12. Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.
Böhle A; Bock PR
Urology; 2004 Apr; 63(4):682-6; discussion 686-7. PubMed ID: 15072879
[TBL] [Abstract][Full Text] [Related]
13. The fate of bacillus Calmette-Guerin after intravesical instillation.
Durek C; Richter E; Basteck A; Rüsch-Gerdes S; Gerdes J; Jocham D; Böhle A
J Urol; 2001 May; 165(5):1765-8. PubMed ID: 11342972
[TBL] [Abstract][Full Text] [Related]
14. Low-dose instillation therapy with bacille Calmette-Guérin Tokyo 172 strain after transurethral resection: historical cohort study.
Yoneyama T; Ohyama C; Imai A; Ishimura H; Hagisawa S; Iwabuchi I; Mori K; Kamimura N; Koie T; Yamato T; Suzuki T
Urology; 2008 Jun; 71(6):1161-5. PubMed ID: 18279920
[TBL] [Abstract][Full Text] [Related]
15. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy.
Shintani Y; Sawada Y; Inagaki T; Kohjimoto Y; Uekado Y; Shinka T
Int J Urol; 2007 Feb; 14(2):140-6. PubMed ID: 17302571
[TBL] [Abstract][Full Text] [Related]
16. A case of disseminated Mycobacterium bovis 2 years post-intravesicular Bacillus Calmette-Guérin therapy for superficial urinary bladder cancer.
Robinson ARL; Radhakrishnan R; Horvath R; Pandey S
Intern Med J; 2017 Jul; 47(7):820-823. PubMed ID: 28677313
[TBL] [Abstract][Full Text] [Related]
17. [Calmette-Guerin bacillus disseminated infection after intravesical instillation].
Borré S; Brustia D; Rosa F; Brondolo R; Rizzo G; Garavelli PL
Recenti Prog Med; 2002 Apr; 93(4):247-8. PubMed ID: 11989131
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of bacille Calmette-Guérin (BCG) infection after intravesical BCG immunotherapy.
Gonzalez OY; Musher DM; Brar I; Furgeson S; Boktour MR; Septimus EJ; Hamill RJ; Graviss EA
Clin Infect Dis; 2003 Jan; 36(2):140-8. PubMed ID: 12522745
[TBL] [Abstract][Full Text] [Related]
19.
Patel A; Elzweig J
BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31857290
[TBL] [Abstract][Full Text] [Related]
20. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study.
Hinotsu S; Akaza H; Isaka S; Kanetake H; Kubota Y; Kuroda M; Shinohara N; Shinka T; Tachibana M; Naito S; Hirao Y;
Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
